Related Videos
A phase I/II Trial investigating safety and efficacy of autologous TAC T cells targeting HER2 in response or refractory solid tumors.
Young-Onset Colorectal Cancer Center Annual Forum Research Keynote
At the Young-Onset Colorectal Cancer Center's third annual Patient and Family Forum, a Research Keynote lead by Jonathan Nowak, MD, PhD and Benjamin Schlechter, MD, discussed immunotherapy and CAR-T cell therapy in young-onset colorectal cancer.
Best Practices for Fertility Preservation
Dana-Farber’s Young-Onset Colorectal Cancer Center's Gut Instincts series continued on Monday, Sept. 27, 2021 with an educational workshop on fertility preservation. This webinar is for healthcare professionals, patients, and supporters.
